Health

Indiana Attorney General Curtis Hill says he’s not opposed to using CBD oil products to treat medical conditions, but with very specific conditions.

Speaking on a panel Wednesday, Hill noted it’s not his role to decide on the legality of those products.

IU Researchers Discover Fragile X Syndrome Link

Dec 12, 2017

Indiana University scientists have identified a new link between a genetic disorder and one of its under-studied characteristics. The research focuses on the abnormal tissue growth of people with what’s called Fragile X Syndrome.

The syndrome is an inherited genetic disorder that is most known for causing intellectual disabilities. IU researcher Arthur Luhur has focused on the biological factors.

“Nobody really knows what happens to the tissues inside the organs with all the focus being on the neuronal problems,” says Luhur.

Lilly Migraine Drug One Step Closer To Market

Dec 11, 2017

A new pain medication, part of Indianapolis-based Eli Lilly’s non-opioid pain management platform, took another step forward.

The drug is called galcanezumab. It’s one of three being crafted by Eli Lilly to treat chronic and serious pain. The medicine has shown promising results in a series of trials says Dr. Robert Conley, Lilly global development leader for migraine.

“Around 60 percent of our patients lost more than half of their headache days and some patients even got to 100 percent loss of headache,” says Conley

Doctors move fast in the ER. Every second counts. That’s why Dr. Gina Huhnke is excited about a new way to quickly check her patients’ history with narcotics. She’s the emergency department director of Deaconess Midtown Hospital in Evansville.


When Ronson Rowley was a teen, he said he used to sneak into a nightclub called the Ten Bar. “It was the only black gay club here in Indianapolis,” he recalled. One night he ran into his uncle.

“He looked me dead in the face,” he recalled. “And [he] said what are you doing here? I said, the same thing you’re doing here.”


Pages